Literature DB >> 11135433

Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted.

H Caron1, N Spieker, M Godfried, M Veenstra, P van Sluis, J de Kraker, P Voûte, R Versteeg.   

Abstract

A previous loss of heterozygosity (LOH) study of a series of 91 neuroblastomas suggested that the 1p35-36 region encodes at least two tumor suppressor genes (TSGs) of importance in neuroblastoma development. Here we present the results of a study including 205 neuroblastomas that were analyzed for LOH at chromosome 1 and MYCN amplification. The results corroborate the existence of two TSGs on 1p. Distinct 1p loci seem to be involved in MYCN single copy vs. MYCN amplified neuroblastoma, as these tumors display a different type of shortest region of overlap (SRO). About 15% of MYCN single copy neuroblastomas show 1p deletions of variable length with an SRO of 47 cR at 1p36.3. The lost alleles are preferentially of maternal origin (P = 0.0002), suggesting parental imprinting of the locus. MYCN amplified neuroblastomas have a contrasting pattern of 1p loss. These tumors display much larger deletions of at least 89 cR comprising the region from 1p36.1 to the telomere. LOH of 1p is detected in 86% of the cases. The lost alleles are of random parental origin, suggesting inactivation of a non-imprinted TSG. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11135433     DOI: 10.1002/1098-2264(200102)30:2<168::aid-gcc1072>3.0.co;2-e

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  19 in total

Review 1.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

2.  A unique role of the DNA fragmentation factor in maintaining genomic stability.

Authors:  Bin Yan; Huili Wang; Yuanlin Peng; Ye Hu; He Wang; Xiuwu Zhang; Qi Chen; Joel S Bedford; Mark W Dewhirst; Chuan-Yuan Li
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  The tumor suppressor Chd5 is induced during neuronal differentiation in the developing mouse brain.

Authors:  Assaf Vestin; Alea A Mills
Journal:  Gene Expr Patterns       Date:  2013-10-09       Impact factor: 1.224

4.  Mechanisms of CHD5 Inactivation in neuroblastomas.

Authors:  Hiroshi Koyama; Tiangang Zhuang; Jennifer E Light; Venkatadri Kolla; Mayumi Higashi; Patrick W McGrady; Wendy B London; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2012-01-31       Impact factor: 12.531

5.  KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death.

Authors:  Arasambattu K Munirajan; Kiyohiro Ando; Akira Mukai; Masato Takahashi; Yusuke Suenaga; Miki Ohira; Tadayuki Koda; Toru Hirota; Toshinori Ozaki; Akira Nakagawara
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

Review 6.  The quest for the 1p36 tumor suppressor.

Authors:  Anindya Bagchi; Alea A Mills
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

Review 7.  Neuroblastoma and MYCN.

Authors:  Miller Huang; William A Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

Review 8.  Molecular and genetic bases of neuroblastoma.

Authors:  Takehiko Kamijo; Akira Nakagawara
Journal:  Int J Clin Oncol       Date:  2012-05-16       Impact factor: 3.402

9.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117

10.  A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Authors:  C Krona; K Ejeskär; H Carén; F Abel; R-M Sjöberg; T Martinsson
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.